Summary
For Year 2026-27, Hamps Bio reports the following shareholding: Total Promoters at 71.99%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 0%, Domestic Institutional Investors at 0%, and Retail at 28.01%. This breakdown provides a quick snapshot of ownership distribution for Hamps Bio in 2026-27.
Hamps Bio FAQs
As of 04-2026, the promoter shareholding in Hamps Bio stands at 71.99% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Hamps Bio is 0% and 0% respectively.
The retail shareholding of the Hamps Bio is 28.01%.
Changes in shareholding patterns of Hamps Bio can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Hamps Bio are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
